Loading…
Corbus Pharmaceuticals Holdings, Inc. is projected to rise to $11.06 by 2027, a +41% move from its current price of $7.82. CRBP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.36 | $7.83 | $8.33 | +0.14% |
| May 30 | $7.18 | $7.84 | $8.56 | +0.28% |
| May 31 | $7.05 | $7.85 | $8.75 | +0.42% |
| Jun 1 | $6.94 | $7.86 | $8.91 | +0.57% |
| Jun 2 | $6.85 | $7.88 | $9.05 | +0.71% |
| Jun 3 | $6.77 | $7.89 | $9.19 | +0.85% |
| Jun 4 | $6.70 | $7.90 | $9.31 | +0.99% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.70 | $7.90 | $9.31 | +0.99% |
| Week 2 | $6.32 | $7.98 | $10.07 | +2.00% |
| Week 3 | $6.05 | $8.06 | $10.72 | +3.01% |
| Week 4 | $5.85 | $8.14 | $11.31 | +4.03% |
| Week 5 | $5.68 | $8.22 | $11.88 | +5.07% |
| Week 6 | $5.54 | $8.30 | $12.43 | +6.11% |
| Week 7 | $5.42 | $8.38 | $12.96 | +7.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is in the Healthcare sector and is currently priced at $7.82 with a market cap of $144.89M. It holds a rank of 3993 among listed securities.
The current price action sits within a high volatility context as reflected by the data, with a range of forecasts that lean neutral in the near term before a broader bullish trajectory emerges.
A major floor 36.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 55.4% above — a clean break opens room to run.
A major ceiling 73.8% above — clearing it would confirm fresh momentum.
Key CRBP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRBP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.66 | Sell | $9.18 | Sell |
| MA 10 | $10.26 | Sell | $9.81 | Sell |
| MA 20 | $10.45 | Sell | $10.14 | Sell |
| MA 50 | $9.97 | Sell | $9.97 | Sell |
| MA 100 | $9.15 | Sell | $9.80 | Sell |
| MA 200 | $10.37 | Sell | $10.30 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.02 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -194.00 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.34 | Sell |
| ROC (12) | -28.65 | Sell |
| Bollinger %B (20,2) | -0.08 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -0.68 | Sell |
| Ultimate (7,14,28) | 32.91 | Neutral |
| Momentum (10) | -3.61 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 9.15 | Sell |
| ADX (14) | 21.54 | Sell |
| ATR (14) | 0.64 | Info |
The 30-day technical picture shows a defined trading range of $5.19 to $11.79. RSI14 is 40, indicating modest downside momentum. SMA50 is $9.97 and SMA200 is $10.37, framing nearby support and resistance levels. The immediate support is at $7.82 and resistance at $12.15, with sentiment labeled BEARISH.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.39 | $7.82 | $13.09 | 0% | Neutral | |
| $7.96 | $11.06 | $16.63 | +41% | Bullish | |
| $8.93 | $13.16 | $21.04 | +68% | Bullish | |
| $7.40 | $11.49 | $19.26 | +47% | Bullish | |
| $7.17 | $11.67 | $20.34 | +49% | Bullish | |
| $7.52 | $12.78 | $23.05 | +63% | Bullish | |
| $8.80 | $15.60 | $29.00 | +100% | Bullish | |
| $11.93 | $22.01 | $42.03 | +181% | Bullish | |
| $11.48 | $22.03 | $43.12 | +182% | Bullish | |
| $10.23 | $20.41 | $40.87 | +161% | Bullish | |
| $16.29 | $36.20 | $79.63 | +363% | Bullish | |
| $20.59 | $45.75 | $105.23 | +485% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.39 | $7.82 | $9.25 | +0.00% |
| June 2026 | $6.72 | $8.06 | $10.01 | +3.05% |
| July 2026 | $7.29 | $8.89 | $11.34 | +10.38% |
| August 2026 | $7.31 | $9.04 | $11.74 | +1.60% |
| September 2026 | $7.12 | $8.90 | $11.75 | -1.51% |
| October 2026 | $7.50 | $9.47 | $12.67 | +6.38% |
| November 2026 | $7.77 | $9.90 | $13.41 | +4.56% |
| December 2026 | $7.43 | $9.55 | $13.09 | -3.50% |
Click any year to see its month-by-month CRBP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Corbus Pharmaceuticals Holdings, Inc.'s 2026 outlook centres on $7.82, within a $7.39 to $13.09 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CRBP could reach as high as $16.63, with a base case around $11.06 and support toward $7.96 — roughly +41% from $7.82. Buyers look set to stay in control over this stretch.
Expect CRBP to range from $8.93 to $21.04 through 2028. The $13.16 average target implies a +68% move from current prices. That is up +19% on the projected 2027 average. Momentum favours further upside here.
The CRBP price prediction for 2029 points to an average of $11.49 (low $7.40, high $19.26) — a potential gain of +47% on today's $7.82. Buyers look set to stay in control over this stretch.
In 2030, CRBP is projected to trade between $7.17 and $20.34, averaging $11.67 — a potential gain of +49% from today's $7.82. That is up +2% on the projected 2029 average. Momentum favours further upside here.
Corbus Pharmaceuticals Holdings, Inc.'s 2031 outlook centres on $12.78, within a $7.52 to $23.05 range. That is up +9% on the projected 2030 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CRBP could reach as high as $29.00, with a base case around $15.60 and support toward $8.80 — roughly +100% from $7.82. Momentum favours further upside here.
Expect CRBP to range from $11.93 to $42.03 through 2033. The $22.01 average target implies a +181% move from current prices. That is up +41% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CRBP price prediction for 2034 points to an average of $22.03 (low $11.48, high $43.12) — a potential gain of +182% on today's $7.82. Momentum favours further upside here.
In 2035, CRBP is projected to trade between $10.23 and $40.87, averaging $20.41 — a potential gain of +161% from today's $7.82. That is -7% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Corbus Pharmaceuticals Holdings, Inc.'s 2040 outlook centres on $36.20, within a $16.29 to $79.63 range. That is up +77% on the projected 2035 average. That marks a +363% change versus current levels. Momentum favours further upside here.
By 2050, CRBP could reach as high as $105.23, with a base case around $45.75 and support toward $20.59 — roughly +485% from $7.82. Buyers look set to stay in control over this stretch.
Investing $1,000 in CRBP today (≈ 127.877238 CRBP) could be worth
$5,850.57
+$4,850.57 (+485%) by 2050 · US Dollar
Based on the average projected CRBP price of $45.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRBPwould be worth at today's price.
$1,000 invested in CRBP on May 27, 2025 (≈ 135.869563 CRBP) would be worth
$1,062.5
+$62.5 (+6.2%) today · 1.06× · US Dollar
Based on a CRBP entry price of $7.36 vs. today's $7.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.73 | $803.7 | -19.6% |
| 1 month ago | $10.08 | $775.79 | -22.4% |
| 3 months ago | $8.25 | $947.88 | -5.2% |
| 6 months ago | $11.54 | $677.64 | -32.2% |
| 1 year ago | $7.36 | $1,062.5 | +6.2% |
| All time (5.0y) ago | $61.5 | $127.15 | -87.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRBP forecast.
Our base-case forecast reaches $16.00 around 2033.
Implied market cap at $16.00: $296.44M
The multi-year forecast paints a bullish trajectory with rising averages and expanding upside. For 2026, the min is $7.39, the avg is $7.82, the max is $13.09, ROI is 0, and sentiment is NEUTRAL. In 2027 the avg is $11.06, max $16.63, ROI 41.5, sentiment BULLISH.
By 2030 the avg is $11.67, max $20.34, ROI 49.2, sentiment BULLISH. The 2040 outlook shows an avg of $36.20, max $79.63, ROI 362.9, sentiment BULLISH. By 2050 the avg is $45.75, max $105.23, ROI 485.1, sentiment BULLISH.
These figures illustrate a long-run bullish trajectory, but they are estimates and not guarantees, subject to market risk and other factors.
Tap a question to reveal the answer.
2030: avg $11.67, min $7.17, max $20.34, ROI 49.2, sentiment BULLISH.
The outlook shows bullish sentiment from 2027 onward, with avg prices rising to $11.06 in 2027 and up to $45.75 by 2050, with notable upside by years like 2032 (avg $15.60, ROI 99.5) and 2040 (avg $36.20, ROI 362.9). These are estimates, not guarantees.
Yes. The 2050 max forecast is $105.23, which exceeds $50.
Current price is $7.82 and market cap is $144.89M.
30-day range is $5.19 to $11.79 with RSI 40, SMA50 $9.97, SMA200 $10.37, support at $7.82 and resistance at $12.15; sentiment is BEARISH.
Corbus Pharmaceuticals Holdings, Inc. Community Discussion
0Share your Corbus Pharmaceuticals Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.